Depth of response to isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: Interim analysis of the GMMG-CONCEPT... von Weisel, Katja, Asemissen, Anne Marie, Besemer, Britta, Haenel, Mathias, Blau, Igor W., Goerner, Martin, Ko, Yon-Dschun, Dürig, Jan, Staib, Peter, Mann, Christoph, Lutz, Raphael, Munder, Markus, Graeven, Ullrich, Peceny, Rudolph, Salwender, Hans, Zago, Manola, Benner, Axel, Tichy, Diana, Bokemeyer, Carsten, Goldschmidt, Hartmut

Volltext